Not only is the LKB1/AMPK signalling axis an integral component of the tumour suppressor network, it is also a critical regulator of energy homoeostasis in the heart under normal conditions and during cardiac disease progression [18,19]. This evidence concerns the gene PRKAA2 and neoplasm.